ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir
Author(s): Verma A, Devine S, Morrow M, Chen YH, Mihalov M, Peace D, Stock W, Pursell K, Wickrema A, Yassine M, Jessop E, van Besin K
Source: BONE MARROW TRANSPLANTATION    Volume: 31    Issue: 9    Pages: 813-816    Published: MAY 2003  
Times Cited: 6     References: 26     
Abstract: To establish the incidence of CMV viremia after allogeneic blood stem cell transplantation, we studied 51 consecutive allogeneic peripheral blood stem cell (PBSC) transplant recipients. A total of 12 recipients were at moderate risk for CMV disease and 39 were at high risk. Conditioning regimens varied, but GvHD prophylaxis consisted of tacrolimus and mini-methotrexate in all patients. All patients received prophylactic ganciclovir from admission until day -2 and prophylactic acyclovir from day -1 until day 180 after transplantation. CMV viremia was treated with ganciclovir. Using a PCR-based technique, the cumulative incidence of CMV viremia was 31 +/- 14% by day 100 and 35 +/- 14% by day 150. Donor type, CMV risk group, underlying disorder, conditioning regimen, GvHD, and steroid use were not associated with the risk for CMV viremia. No cases of CMV disease occurred. We hypothesize that the low rate of CMV viremia and the absence of CMV disease in this cohort of PBSCT transplant recipients, which contrasts with other reports, may be related to the prophylactic use of high-dose acyclovir and possibly to pretransplant use of ganciclovir.
Document Type: Article
Language: English
Reprint Address: van Besin, K (reprint author), Univ Chicago, Sect Hematol Oncol, Dept Med, 5847 S Maryland Ave,Rm 1 209, Chicago, IL 60637 USA
Addresses:
1. Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL 60637 USA
2. Univ Illinois, Dept Pathol, Sect Hematol Oncol, Chicago, IL USA
Publisher: NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
Subject Category: Biophysics; Oncology; Hematology; Immunology; Transplantation
IDS Number: 681FB
ISSN: 0268-3369
DOI: 10.1038/sj.bmt.1703916
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo